Answers are grounded in this paper and cite their sources.
In a recent study published in The New England Journal of Medicine, Liang and colleagues report that subretinal delivery of scAAV8-hRS1 to 12 children with X-linked retinoschisis (XLRS) resulted in closure of macular schisis by 13 weeks in all treated eyes and restoration of outer retinal structure in most participants. 1 These findings provide encouraging evidence that RS1 gene augmentation can substantially improve retinal structure in X-linked retinoschisis, while raising the important question of whether anatomical rescue will translate into meaningful and durable improvements in visual function.
No takes yet. Share an insight, caveat, or question.
Jamieson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: